🔎 Trials Near Me

Akèy › Maladi poumon entèstisyèl › Ohio

Etid klinik pou Maladi poumon entèstisyèl nan Ohio

14 etid pou Maladi poumon entèstisyèl ap chèche patisipan nan sit nan Ohio.

Vil nan Ohio

Tèks ofisyèl etid la (Anglè)

LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • University of Cincinnati Department of Internal Medicine Pulmonary, Critical Care & Sleep Medicine, Cincinnati
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 29, 2026 · NCT05798923

FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression

  • University Hospitals Cleveland Medical Center, Cleveland
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07540988

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

  • GSK Investigational Site, Cincinnati
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT05878717

A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

  • University of Cincinnati Medical Center, Cincinnati
Ap rekriteFaz 2
Laj 40 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT06968845

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

  • University Hospitals Cleveland Medical Center, Cleveland
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT06911632

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • University of Cincinnati Medical Center, Cincinnati
  • University Hospitals Cleveland Medical Center, Cleveland
  • The Cleveland Clinic, Cleveland
  • ak 1 plis
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 26, 2026 · NCT06388421

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

  • Cleveland Clinic, Cleveland
  • The Ohio State University, Columbus
Ap rekriteEtid obsèvasyon
Laj 21 ak plis · Tout sèks · Mizajou Aug 12, 2026 · NCT01915511

Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease

  • Cincinnati Children's Hospital Medical Center, Cincinnati
Ap rekriteFaz 2
Laj 4 ak plis · Tout sèks · Mizajou Jul 22, 2026 · NCT04925375

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

  • University of Cincinnati Medical Center, Cincinnati
  • St. Luke's Univeristy Health Network-Pulmonary & Critical Care, Cincinnati
  • The Ohio State University Wexner Medical CEnter, Columbus
  • ak 1 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Jul 13, 2026 · NCT05943535

TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients

  • Cincinnati Children's Hospital Medical Center, Cincinnati
Ap rekriteEtid obsèvasyon
Jiska laj 24 · Tout sèks · Mizajou Jun 22, 2026 · NCT04098445

A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants

  • GSK Investigational Site, Columbus
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 65 · Tout sèks · Mizajou Jun 22, 2026 · NCT06576271

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

  • aTyr Investigative Site, Cleveland
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou May 7, 2025 · NCT05892614

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.